Page results
-
The plasma exchange service at the National Hospital treats patients with neuroimmunological diseases such as Guillain-Barré syndrome and myasthenia gravis.
-
The spasticity service at NHNN offers a comprehensive, responsive multidisciplinary service to adults with spasticity associated with any neurological condition.
-
We provide a specialist spinal surgery service including treatment of degenerative spinal conditions, artificial discs, spinal injury, spinal tumours (intra and extra dural, including metastatic disease), scoliosis and syringomyelia.
-
The cochlear implant programme was founded in 1982, and we were the first clinical cochlear implant programme in the UK. The team has been involved with the successful implantation of more than 2,000 patients, both adults and children, from all over the UK.
-
A guide to choosing diabetes technology for UCLH patients
-
This information is for patients who are having radiotherapy for a base of skull tumour. It explains what the treatment involves, describes side-effects you may experience during and after treatment, and how best to cope with them.
-
Once you have completed treatment for cancer at UCLH you will enter a period of follow-up care. Follow-up is an important way of monitoring your health.
-
The service offers a holistic, multidisciplinary approach to the evaluation and treatment of bladder, bowel and sexual dysfunction in individuals with established and suspected neurological disorders.
-
Many of our consultants in infectious and tropical diseases hold the only dedicated NHS positions in their respective fields, including parasitology, leprosy, leishmaniasis, and tropical dermatology.
-
This page has been written for all pregnant women, their partners and families who are having care at UCLH and have been offered an 11-14 week first trimester scan.
File results
-
FOI/2024/0312 - Cleaning brushes and theatre equipment in sterilisation decontamination unit
-
FOI/2024/0317 - Physician associate/ Anaesthesia associate shift hours 2010-2023
-
FOI/2024/0318 - Patients absconded from medium/ high-security psychiatric facilities
-
FOI/2024/0320 - Treatment for rare diseases; fabry, gaucher and pompe diseases
-
FOI/2024/0326 - Treatment of Haemophilia B and Von Willebrand disease
-
FOI/2024/0327 - Treatment of non-UK nationals
-
FOI/2024/0329 - Metastatic renal cell carcinoma patients/ classification
-
FOI/2024/0464 - Theatre sessions/ productivity
-
FOI/2024/0467 - Drug Patient Level Contract Monitoring (DrPLCM) and SACT Cancer reports
-
FOI/2024/0333 - Elective treatment wait over 65 weeks